ceftolozane: Clinical Trials

2 trials of ceftolozane, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Completed 2

Follow ceftolozane: new trials by email Literature Review of ceftolozane trials Research Report on ceftolozane

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Ceftolozane/Tazobactam (MK-7625A) in Japanese Participants With Uncomplicated Pyelonephritis and Complicated Urinary Tract Infection (MK-7625A-014)
MK-7625A 1.5 g (ceftolozane 1 g/tazobactam 0.5 g) - Urinary Tract Infection (UTI), Complicated Urinary Tract Infection
Phase 3CompletedMerck Sharp & Dohme LLC1152016-04-142019-02-05
Study of Ceftolozane/Tazobactam (MK-7625A) in Combination With Metronidazole in Japanese Participants With Complicated Intra-abdominal Infection (MK-7625A-013)
MK-7625A 1.5 g (ceftolozane 1 g/tazobactam 0.5 g), metronidazole 500 mg - Intra-abdominal Infection, Complicated Intra-abdominal Infection
Phase 3CompletedMerck Sharp & Dohme LLC1002016-04-082018-08-09

Conditions studied

Intraabdominal Infections (1)  ·  Pyelonephritis (1)  ·  Urinary Tract Infections (1)

Sponsors

Merck Sharp & Dohme LLC (2)

Results publications

PMID 30528561, PMID 40913503